Zobrazeno 1 - 10
of 392
pro vyhledávání: '"Sabarish V"'
Publikováno v:
Virtual Worlds, Vol 3, Iss 1, Pp 94-114 (2024)
In this contribution, we propose a hybrid interaction technique that integrates near-field and object-space interaction techniques for manipulating objects at a distance in virtual reality (VR). The objective of the hybrid interaction technique was t
Externí odkaz:
https://doaj.org/article/577bfd8787664f30a5e943deb5c98af4
Publikováno v:
Virtual Worlds, Vol 3, Iss 1, Pp 1-20 (2023)
Design discussion is crucial in the architectural design process. To enhance the spatial understanding of 3D space and discussion effectiveness, recently, some systems have been proposed to support design discussion interactively in an immersive virt
Externí odkaz:
https://doaj.org/article/7a4613ee3a5244aa89d6bd49b27b0060
Autor:
Velmurugan Balaraman, Sabarish V. Indran, In Joong Kim, Jessie D. Trujillo, David A. Meekins, Vinay Shivanna, Michelle D. Zajac, Kinga Urbaniak, Igor Morozov, Sun-Young Sunwoo, Bonto Faburay, Klaus Osterrieder, Natasha N. Gaudreault, William C. Wilson, Juergen A. Richt
Publikováno v:
Viruses, Vol 16, Iss 6, p 880 (2024)
Rift Valley fever (RVF) in ungulates and humans is caused by a mosquito-borne RVF phlebovirus (RVFV). Live attenuated vaccines are used in livestock (sheep and cattle) to control RVF in endemic regions during outbreaks. The ability of two or more dif
Externí odkaz:
https://doaj.org/article/9b0b72b5e80b48b78f175e4ae36af87f
Autor:
Bianca L. Artiaga, Igor Morozov, Russell Ransburgh, Taeyong Kwon, Velmurugan Balaraman, Sabarish V. Indran, Darling Melany De Carvalho Madrid, Weihong Gu, Jamie Henningson, Wenjun Ma, Jürgen A. Richt, John P. Driver
Publikováno v:
Animal Diseases, Vol 2, Iss 1, Pp 1-15 (2022)
Abstract Natural killer T (NKT) cells activated with the glycolipid ligand α-galactosylceramide (α-GalCer) stimulate a wide variety of immune cells that enhance vaccine-mediated immune responses. Several studies have used this approach to adjuvant
Externí odkaz:
https://doaj.org/article/ea1265ba55ee48449878b912d3357abe
Autor:
Igor Morozov, Natasha N. Gaudreault, Jessie D. Trujillo, Sabarish V. Indran, Konner Cool, Taeyong Kwon, David A. Meekins, Velmurugan Balaraman, Bianca Libanori Artiaga, Daniel W. Madden, Chester McDowell, Bradley Njaa, Jamie Retallick, Nicole Hainer, Jason Millership, William C. Wilson, George Tkalcevic, Hanne Vander Horst, Yulia Burakova, Vickie King, Kendra Hutchinson, John M. Hardham, Denise J. Schwahn, Mahesh Kumar, Juergen A. Richt
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1831 (2023)
The objective of this work was to evaluate the safety and efficacy of a recombinant, subunit SARS-CoV-2 animal vaccine in cats against virulent SARS-CoV-2 challenge. Two groups of cats were immunized with two doses of either a recombinant SARS-CoV-2
Externí odkaz:
https://doaj.org/article/314f5e2000de4c84b8e72ad714604fa4
Autor:
Velmurugan Balaraman, Sabarish V. Indran, Yonghai Li, David A. Meekins, Laxmi U. M. R. Jakkula, Heidi Liu, Micheal P. Hays, Jayme A. Souza-Neto, Natasha N. Gaudreault, Philip R. Hardwidge, William C. Wilson, Friedemann Weber, Juergen A. Richt
Publikováno v:
Viruses, Vol 15, Iss 11, p 2251 (2023)
Rift Valley fever phlebovirus (RVFV) is a zoonotic pathogen that causes Rift Valley fever (RVF) in livestock and humans. Currently, there is no licensed human vaccine or antiviral drug to control RVF. Although multiple species of animals and humans a
Externí odkaz:
https://doaj.org/article/8f3f75e0424549dea65269439557e108
Autor:
Igor Morozov, Thomas P. Monath, David A. Meekins, Jessie D. Trujillo, Sun-Young Sunwoo, Kinga Urbaniak, In Joong Kim, Sanjeev K. Narayanan, Sabarish V. Indran, Wenjun Ma, William C. Wilson, Cassandra O'Connor, Sheri Dubey, Sean P. Troth, Beth-Ann Coller, Richard Nichols, Brian K. Martin, Heinz Feldmann, Juergen A. Richt
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 651-663 (2021)
The recent impact of Ebola virus disease (EVD) on public health in Africa clearly demonstrates the need for a safe and efficacious vaccine to control outbreaks and mitigate its threat to global health. ERVEBO® is an effective recombinant Vesicular S
Externí odkaz:
https://doaj.org/article/76a36bca1a3948bfb5561339b098a75b
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Abstract Lack of standardization and unblinding threaten the research of mechanisms involved in expectancy effects on pain. We evaluated a computer-controlled virtual experimenter (VEx) to avoid these issues. Fifty-four subjects underwent a baseline-
Externí odkaz:
https://doaj.org/article/4d3a4b360f3e4ed8855d44a3aacf7938
Autor:
Natasha N. Gaudreault, Jessie D. Trujillo, Mariano Carossino, David A. Meekins, Igor Morozov, Daniel W. Madden, Sabarish V. Indran, Dashzeveg Bold, Velmurugan Balaraman, Taeyong Kwon, Bianca Libanori Artiaga, Konner Cool, Adolfo García-Sastre, Wenjun Ma, William C. Wilson, Jamie Henningson, Udeni B. R. Balasuriya, Juergen A. Richt
Publikováno v:
Emerging Microbes and Infections, Vol 9, Iss 1, Pp 2322-2332 (2020)
ABSTRACTSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the cause of Coronavirus Disease 2019 (COVID-19) and responsible for the current pandemic. Recent SARS-CoV-2 susceptibility studies in cats show that the virus can replicate in t
Externí odkaz:
https://doaj.org/article/2c2d54a0deaf4b9fa953183c831213ce
Autor:
David A. Meekins, Igor Morozov, Jessie D. Trujillo, Natasha N. Gaudreault, Dashzeveg Bold, Mariano Carossino, Bianca L. Artiaga, Sabarish V. Indran, Taeyong Kwon, Velmurugan Balaraman, Daniel W. Madden, Heinz Feldmann, Jamie Henningson, Wenjun Ma, Udeni B. R. Balasuriya, Juergen A. Richt
Publikováno v:
Emerging Microbes and Infections, Vol 9, Iss 1, Pp 2278-2288 (2020)
ABSTRACTThe emergence of SARS-CoV-2 has resulted in an ongoing global pandemic with significant morbidity, mortality, and economic consequences. The susceptibility of different animal species to SARS-CoV-2 is of concern due to the potential for inter
Externí odkaz:
https://doaj.org/article/e4589c3202cf495da942dfffa8ce8369